 |
W20 has acquired Radius Digital Science, the Montclair, NJ-based firm that calls itself a “scientific visualization” company.
The 25-member RDS team creates digital images that help people understand science, apps that explain diseases, animations that show how medical therapies work and materials that provide guidance for patients.
Staffers also are experienced with molecular visualization, UX design/programming, medical illustration, 3D animation and experiential media for presentations at scientific conferences and trade shows.
W2O has worked with RDS to “bring our clients’ science to life thorugh more dynamic and impactful digital media and evocative artistic expression,” said CEO Jim Weiss.
He said the acquisition of the firm co-founded by Michelle Peterson and Brandon Pletsch diversifies W2O’s “marketeching” toolbox and “raises the bar for how we execute on scientific creative across our suite of integrated capabilities.”
W2O is O'Dwyer's No. 1 ranked healthcare firm with fees of $168.1M in 2018.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
